Global Sciatica Market Size study, by Types (Acute, Chronic and Others), By Pharmacological Therapies (Non-Steroidal Anti-inflammatory Drug (NSAIDs), Steroids, Antidepressants, Painkillers and Others), and Regional Forecasts 2022-2028

Global Sciatica Market Size study, by Types (Acute, Chronic and Others), By Pharmacological Therapies (Non-Steroidal Anti-inflammatory Drug (NSAIDs), Steroids, Antidepressants, Painkillers and Others), and Regional Forecasts 2022-2028

Global Sciatica Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.5% over the forecast period 2022-2028. Sciatica is a medical ailment that causes moderate to severe pain along the sciatic nerve, which flows from the lower back through the hips and buttocks and down to the legs. It usually occurs when a herniated disc, a bone spur on the spine, or spinal stenosis compresses a portion of the nerve. The market is driven by the risk factors and increasing elderly population and increased public awareness and high survival rate of sciatica. According to the Centers for Disease Control and Prevention, over three out of five persons (58.9%) in the United States had pain of some type in the previous three months of 2019. Back pain affected 39.0 percent of adults, 36.5 percent of adults had lower limb pain, and 30.7 percent of adults had upper limb pain. The incidence of pain in each of these areas rose with age, with the highest frequency among individuals aged 65 and more. Men and non-Hispanic Asian people had the lowest pain prevalence in each of these areas. Furthermore, high expenditure on healthcare boosts the market opportunities in the coming years. However, several off-label drugs and physical therapy in the market impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Sciatica Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the market shares globally and is expected to be the fastest growing region in the forecast years, owing to favorable demand for disease-specific novel treatment and increase in government investment in healthcare.

Major market players included in this report are:
Sorrento Therapeutics
Sinfonia Biotherapeutics
Eliem Therapeutics
Aurobindo Pharma
SpineThera
Kolon life Science
Scilex Holding
Vita Sciences
Seikagaku Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Types:
Acute Sciatica
Chronic Sciatica
Others

By Pharmacological Therapies:
Non-Steroidal Anti-inflammatory Drug (NSAIDs)
Steroids
Antidepressants
Painkillers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Sciatica Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Sorrento Therapeutics
Sinfonia Biotherapeutics
Eliem Therapeutics
Aurobindo Pharma
SpineThera
Kolon life Science
Scilex Holding
Vita Sciences
Seikagaku Corporation

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.